Probactive Biotech, Inc. Announces an Agreement to Co-Develop Novel Biopharmaceuticals for Cancer with Dalat Nuclear Research Institute of Vietnam

Tuesday, June 22, 2010 Corporate News
Email Print This Page Comment
Font : A-A+

Contact:

Henry Smith, Ph.D.

Probactive Biotech, Inc.

11555 Monarch Street

Garden Grove, CA 92841

Phone: (714) 903-1000

Fax: (714) 903-1010

Info@Probactive.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook